Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Midomafetamine by Lykos Therapeutics for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
Midomafetamine is under clinical development by Lykos Therapeutics and currently in Pre-Registration for Post-Traumatic Stress Disorder (PTSD). According to GlobalData,...
Data Insights
Midomafetamine by Lykos Therapeutics for Social Anxiety Disorder (SAD/Social Phobia): Likelihood of Approval
Midomafetamine is under clinical development by Lykos Therapeutics and currently in Phase II for Social Anxiety Disorder (SAD/Social Phobia). According...